Supply and procurement

in page functions

18 November 2014

Penta Roadmap Public Summary

The development of hepatitis B (hepB) and Haemophilus influenzae type b (Hib) vaccination through the uptake of pentavalent routine immunization represents the most significant Gavi achievement to date.

  • Author(s):
  • Gavi, the Vaccine Alliance
  • Total pages:
  • 5

18 November 2014

Pneumococcal vaccine roadmap: public summary

From 2010 to 2014, Gavi, the Vaccine Alliance support to increase access to vaccines against Streptococcus pneumoniae (pneumococcus) has led to major achievements:

  • The first introductions of pneumococcal conjugate vaccines (PCVs: PCV10 and PCV13) in Gavi-eligible countries occurred two years after their first introductions in high-income countries.
  • The manufacturing capacity available to the Vaccine Alliance increased from under 20 million doses in 2010 to over 100 million in 2014.
  • Author(s):
  • Gavi, the Vaccine Alliance
  • Total pages:
  • 6

29 September 2014

GAVI Strategic Demand Forecast 2014

For more than 4 years, the GAVI Alliance has been using SDFs to improve its understanding of vaccine markets. In the context of the GAVI Alliance Supply and Procurement Strategy, the SDF is an important tool to ensure clarity and understanding of the GAVI market for important stakeholders, including manufacturers, donors, and countries.

07 July 2014

Measles-rubella vaccine roadmap: public summary

The GAVI Alliance began funding measles-rubella (MR) vaccine catch-up campaigns iin 2011. This document is the public summary of the supply and procurement roadmap for MR, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 4

07 July 2014

Japanese encephalitis vaccine roadmap: public summary

The GAVI Alliance opened a funding window for Japanese encephalitis (JE) vaccination catch-up campaigns in endemic countries at its November 2013 Board meeting. This document is the public summary of the supply and procurement roadmap for JE, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 5

31 October 2013

Rotavirus Roadmap Public Summary

Rotavirus is the leading cause of severe diarrhoea in children under five years of age worldwide. GAVI’s rotavirus vaccine programme was initiated in 2011. This document is the public summary of the supply and procurement roadmap for rotavirus vaccine, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 4

31 October 2013

IPV Roadmap Public Summary

In 2013, the GAVI Board decided to begin supporting the introduction of inactivated polio vaccine (IPV) as part of routine immunisation programmes in the world’s 73 poorest countries. This document is the public summary of the supply and procurement roadmap for IPV, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 5

30 July 2013

Yellow Fever Roadmap Public Summary

In support of WHO efforts to control the disease, GAVI has been engaged in Yellow Fever (YF) vaccination since 2001. Yellow fever vaccination reduces the burden of a disease that has no cure, 90% of which is reported in the African region.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 4

30 October 2012

GAVI Vaccine Supply and Procurement Strategy 2011-2015

1 The GAVI Alliance Vaccine Supply and Procurement Strategy for the period 2011-2015 VERSION NUMBER APPROVAL PROCESS DATE 1.0 Reviewed by: GAVI Programme and Policy Committee 28 September 2011 Approved by: GAVI Alliance Board 17 November 2011 Effective from: approval date Review: in 2014, in preparation for the develop

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 23

30 October 2012

HPV Supply and Procurement Roadmap

HPV Supply and Procurement Roadmap www.gavialliance.org UPDATE 2012 1 PUBLIC SUMMARY Supply and Procurement Roadmap HPV (Human Papilloma Virus) Vaccine The market-shaping goal Shape vaccine markets to provide appropriate and affordable vaccines HPV Supply and Procurement Roadmap www.gavialliance.org UPDATE 2012 2 The G

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 5

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please




close icon

modal window here